Nevertheless, AT2 cell hypertrophy was described in transgenic mice overexpressing IL-13 (29), a key mediator of lung Th2 immune diseases, such as asthma and fibrosis, and in a murine model of pulmonary fibrosis caused by TGF-β1 overexpression (30). Here, TGFB1 is linked to pulmonary fibrosis.